![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.biopharmadive.com/news/uniqure-genezen-lexington-manufacturing-sale-gene-therapy/720266/
https://www.fiercepharma.com/manufacturing/csl-behring-shuts-down-filling-department-lays-65-staffers-major-illinois-site
https://www.fiercepharma.com/pharma/kyowa-kirins-orchard-sets-new-gene-therapy-price-tag-425m-steepest-any-drug-us
https://www.midas-pharma.com/en/latest-activities/midas-team-ready-for-pharma-cup-2024/
https://endpts.com/csl-and-uniqures-three-year-hemgenix-data-show-consistent-effect-in-hemophilia-b/
https://www.prnewswire.com/news-releases/csl-behring-announces-availability-of-hizentra-immune-globulin-subcutaneous-human-20-liquid-10g-prefilled-syringe-302024891.html
https://www.prnewswire.com/news-releases/csl-behring-demonstrates-continued-commitment-to-alpha-1-community-with-addition-of-zemaira-alpha1-proteinase-inhibitor-human-4--and-5-gram-vials-302024123.html
https://endpts.com/fda-ema-accept-pfizers-hemophilia-b-gene-therapy-setting-up-showdown-with-csl-behring/
https://www.pharmaceutical-technology.com/news/csl-first-patient-hemgenix-haemophilia-b/
https://www.ema.europa.eu/en/documents/overview/hemgenix-epar-medicine-overview_en.pdf